Table 3.
Hazard ratios for mortality of patients with heart failure according to the medians of ALI and GNRI
| Unadjusted | Model 1 | Model 2 | Model 3 | |||||
|---|---|---|---|---|---|---|---|---|
| Groups | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p |
| Group 4 (n = 264) | 1 | 1 | 1 | 1 | ||||
| Group 1 (n = 264) | 3.113 (2.468, 3.926) | < 0.001 | 2.656 (2.096–3.366) | < 0.001 | 2.616 (2.064–3.316) | < 0.001 | 2.056 (1.604–2.635) | < 0.001 |
| Group 2 (n = 177) | 2.067 (1.589, 2.689) | < 0.001 | 1.880 (1.444–2.449) | < 0.001 | 1.817 (1.395–2.368) | < 0.001 | 1.264 (0.954–1.673) | 0.102 |
| Group 3 (n = 177) | 1.166 (0.869,1.564) | 0.307 | 1.130 (0.842,1.517) | 0.416 | 1.169 (0.871,1.570) | 0.298 | 1.244 (0.923,1.677) | 0.151 |
① Group 1, Group 2 and Group 3 all used Group 4 as the reference group
② Group 1 (ALI < 24.60 and GNRI < 94.41); Group 2 (ALI < 24.60 and GNRI ≥ 94.41); Group 3 (ALI ≥ 24.60 and GNRI < 94.41); Group 4 (ALI ≥ 24.60 and GNRI ≥ 94.41)
③ Model 1: adjusted for age; Model 2: adjusted for age, NYHA class and diastolic BP; Model 3: adjusted for Model 2 + CRP, AST, uric acid, chloride, lg BNP
④ ALI advanced lung cancer inflammation index, GNRI geriatric nutritional risk index, HR hazard ratio, CI confidence interval, NYHA New York Heart Association, BP blood pressure, CRP C-reactive protein, AST aspartate aminotransferase, BNP brain natriuretic peptide